drogatule - FACEIT level 10, 2,587 ELO

Romania
On FACEIT since 2025 97 matches tracked 66 matches in 30 days
Last updated:

drogatule at a glance

Level 10 2,587 ELO best map Mirage (58%)
2,500-2,749 ELO

Last 20 matches compared with 2,994 players in this group: K/R, ADR and win rate above average.

RatingCalculated with the HLTV Rating 1.0 formula from kills, deaths and multi-kills per round. 1.00 is an average match.
better than 64%
1.09
SpreadHow much the rating swings from match to match. The smaller, the more consistent. ±0.28 ConsistencyShare of matches with a rating of 0.90 or higher. 80%
K/R
0.78
better than 65% of players
2,500-2,749 ELO avg: 0.75
Last 12 months
ADR
84.9
better than 67% of players
2,500-2,749 ELO avg: 81.1
Last 12 months
Win rate
60%
better than 74% of players
2,500-2,749 ELO avg: 50%
Last 12 months

Facts

113 ELO Next goal That is 3 to 5 wins.
5 W · 0 L Best day +102 ELO · Sep 20, 2026
4 Comebacks since Aug 1, 2026
5 W · 0 L Overtime in overtime
Mirage Favorite map 36 of 97 matches
Mirage 58% Map pool tip weakest: Ancient 30%
1 Zeus kill Rare kills 2 knife kills
14:00-20:00 Playing times most active
FormMapsTiming

113 ELO away from 2,700 ELO. That is 3 to 5 wins. 5:0 on Sep 20, 2026 (+102 ELO, last 90 days). 4 wins after trailing at halftime (since Aug 1, 2026). 5 matches in overtime, 5 of them won (since Aug 1, 2026). Most played: Mirage (36 of 97 matches). Strongest map: Mirage (58% win rate, 36 matches). Weakest: Ancient (30%, 10 matches). 1 Zeus kill and 2 knife kills (since Aug 1, 2026). Plays most between 14:00 and 20:00 (based on 97 matches).

About drogatule

drogatule plays CS2 on FACEIT level 10 with 2,587 ELO. The stats cover 97 matches. drogatule plays Mirage the most and wins it the most: 58% win rate in 36 matches. Biggest strength: 3K rounds at 5.9%, better than 94% of level 10 · 2,500-2,749 ELO players. drogatule won 4 matches after trailing at halftime (since Aug 1, 2026). Last 20 matches: 12 wins, 8 losses, +128 ELO. Previously known as inarmat, gbii7, cheater6767 and others.